Osaic Holdings’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Other funds holding FATE
Osaic Holdings's FATE Position: Q3 2026 in Review
Osaic Holdings reduced its Fate Therapeutics (FATE) stake by 9.3% in Q3 2026, selling an estimated $155 and leaving 585 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #7442.
Osaic Holdings first reported a position in FATE in Q1 2020 and has held it in 27 quarters since. The position peaked at $401K in Q1 2022. 142 funds tracked by Wall St. Rank hold FATE as of Q3 2026.
- Osaic Holdings held 585 shares of Fate Therapeutics worth $1.38K as of Q3 2026.
- Osaic Holdings sold 60 Fate Therapeutics shares in Q3 2026, an estimated $155.
- Fate Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7442 holding.
- Osaic Holdings first reported a position in Fate Therapeutics in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Fate Therapeutics position peaked at $401K in Q1 2022.
- 142 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.